The effects of melatonin, aluminum oxide, and polymethylsiloxane complex on the expression of LYVE-1 (lymphatic vessel endothelial hyaluronan receptor) in the liver were studied in db/db mice with experimental obesity and type 2 diabetes mellitus. The complex or placebo was administered daily by gavage from week 8 to week 16 of life. The animals receiving the complex exhibited enhanced, in comparison with the placebo group, immunohistochemical LYVE-1+ staining of endothelial cells in sinusoids. Enhanced expression of LYVE-1 was associated with less pronounced dilatation of interlobular arteries, veins, and lymphatic vessels. Thee findings suggest a protective effect of the complex towards structural changes in the liver of mice with obesity and type 2 diabetes.
Similar content being viewed by others
References
Borodin YuI, Trufakin VA, Michurina SV, Shurlygina AV. Structural and temporal organization of the liver, lymphatic, immune, and endocrine systems under conditions of abnormal lighting regimen and melatonin treatment. Novosibirsk, 2012. Russian.
Konenkov VI, Klimontov VV, Michurina SV, Prudnikova MA, Ishenko IJu. Melatonin and diabetes: from pathophysiology to the treatment perspectives. Sakh. Diabet. 2013;(2):11-16. Russian.
3 Konenkov VI, Borodin YuI, Lyubarskii MS. Lympholohy. Novosibirsk, 2012. Russian.
Michurina SV, Rachkovskaja LN, Ishchenko IJ, Rachkovskij EE, Klimontov VV, Konenkov VI. Patent RF No. 2577580. Alumina-based porous sorbent with chronotropic properties. Bull. No. Published March 20, 2016.
Rapoport SI, Golichenkova VA. Melatonin: Theory and Practics. Moscow, 2009. Russian.
Arimoto J, Ikura Y, Suekane T, Nakagawa M, Kitabayashi C, Iwasa Y, Sugioka K, Naruko T, Arakawa T, Ueda M. Expression of LYVE-1 in sinusoidal endothelium is reduced in chronically inflamed human livers. J. Gastroenterol. 2010;45(3):317-325.
Bernaudin JF, Kambouchner M, Lacave R. Lymphatic vascular system, development and lymph formation. Review. Rev. Pneumol. Clin. 2013;69(2):93-101.
Ekmekcioglu C. Melatonin receptors in humans: biological role and clinical relevance. Biomed. Pharmacother. 2006;60(3):97-108.
Hatzis G, Ziakas P, Kavantzas N, Triantafyllou A, Sigalas P, Andreadou I, Ioannidis K, Chatzis S, Filis K, Papalampros A, Sigala F. Melatonin attenuates high fat diet-induced fatty liver disease in rats. World J. Hepatol. 2013;5(4):160-169.
Hu J, Srivastava K, Wieland M, Runge A, Mogler C, Besemfelder E, Terhardt D, Vogel MJ, Cao L, Korn C, Bartels S, Thomas M, Augustin HG. Endothelial cell-derived angiopoietin-2 controls liver regeneration as a spatiotemporal rheostat. Science. 2014;343:416-419.
Martín M, Macías M, León J, Escames G, Khaldy H, Acuña-Castroviejo D. Melatonin increases the activity of the oxidative phosphorylation enzymes and the production of ATP in rat brain and liver mitochondria. Int. J. Biochem. Cell Biol. 2002;34(4):348-357.
Nagorny C, Lyssenko V. Tired of diabetes genetics? Circadian rhythms and diabetes: the MTNR1B story? Curr. Diab. Rep. 2012;12(6):667-672.
Pandi-Perumal SR, Trakht I, Srinivasan V, Spence DW, Maestroni GJ, Zisapel N, Cardinali DP. Physiological effects of melatonin: role of melatonin receptors and signal transduction pathways. Prog. Neurobiol. 2008;85(3):335-353.
Peschke E. Melatonin, endocrine pancreas and diabetes. J. Pineal Res. 2008;44(1):26-40.
Sahna E, Parlakpinar H, Vardi N, Ciğremis Y, Acet A. Efficacy of melatonin as protectant against oxidative stress and structural changes in liver tissue in pinealectomized rats. Acta Histochem. 2004;106(5):331-336.
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 162, No. 8, pp. 238-241, August, 2016
Rights and permissions
About this article
Cite this article
Michurina, S.V., Ishchenko, I.Y., Arkhipov, S.A. et al. Effects of Melatonin, Aluminum Oxide, and Polymethylsiloxane Complex on the Expression of LYVE-1 in the Liver of Mice with Obesity and Type 2 Diabetes Mellitus. Bull Exp Biol Med 162, 269–272 (2016). https://doi.org/10.1007/s10517-016-3592-y
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-016-3592-y